1. Scrip

Korea Needs To Think Bigger On M&As: KHIDI

Calls For Govt Support To Boost Activity

 
• By Jung Won Shin and Kosh Naran

A new report from a domestic institute on South Korea’s biopharma M&A trends shows a pickup in activity, but that this remains relatively weak and small-scale. It calls for broader domestic government support to build expertise, drive innovation and globalization.

M&A
Government Support Needed To Boost M&As In Korea (Shutterstock)

Mergers and acquisitions usually happen in major global biopharma markets as a way to gain new technologies, R&D or commercial portfolios, expand a business or to beef up supply networks.

But in South Korea, M&A activity has only begun to pick up slowly in recent years and transactions have, in general, been smaller in scale and led by

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

More from Financing